Ausgabe 2/2015
Inhalt (7 Artikel)
Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis
Mohammad Shahjahani, Javad Mohammadiasl, Fatemeh Noroozi, Mohammad Seghatoleslami, Saeid Shahrabi, Fakhredin Saba, Najmaldin Saki
Chlorogenic acid inhibits hypoxia-induced angiogenesis via down-regulation of the HIF-1α/AKT pathway
Jin Ju Park, Su Jung Hwang, Ji-Hyeon Park, Hyo-Jong Lee
Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib
Kristy J. Gotink, Maria Rovithi, Richard R. de Haas, Richard J. Honeywell, Henk Dekker, Dennis Poel, Kaamar Azijli, Godefridus J. Peters, Henk J. Broxterman, Henk M. W. Verheul
Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts
Armin Maier, Anne-Lise Peille, Vincent Vuaroqueaux, Michael Lahn
Epidermal growth factor receptor mutations in East European non-small cell lung cancer patients
Stoyan Naidenov Bichev, Dora Marinova Marinova, Yanina Georgieva Slavova, Alexey Slavkov Savov
Synergy of leptin/STAT3 with HER2 receptor induces tamoxifen resistance in breast cancer cells through regulation of apoptosis-related genes
Vassilis Papanikolaou, Nikolaos Stefanou, Stephanie Dubos, Ioanna Papathanasiou, Maria Palianopoulou, Vaia Valiakou, Aspasia Tsezou
Associations between polymorphisms in the SYK promoter and susceptibility to sporadic colorectal cancer in a Southern Han Chinese population - a short report
Hui Peng, Jun Huang, Ying Hu, Yisheng Wei, Huanliang Liu, Meijin Huang, Lei Wang, Jianping Wang